Heart Failure: Review on Pathophysiology and Pharmacological Therapy

Carvedilol protects against Cognitive Dysfunction Through Inhibition of Amyloid Beta (1-42) and Inflammation in Aluminum Chloride Induced Alzheimer’s Disease compared to Donepezil

Role of GRK5/β-arrestin2 pathway in mediating the cardioprotective effects of carvedilol in 5/6 nephrectomized rats

Pharmacogenomics and Heart Failure Patients on Carvedilol

Carvedilol and rosuvastatin mitigate nephrotoxicity of sodium valproate through activation of Nrf2 pathway in rats.

The Cardioprotective Role of Carvedilol, A Non-Selective -Adrenoceptor Blocker, in Albino Rats with Type 2 Diabetes Mellitus

Application of Several Nano Carriers to Improve the Solubility and the Bioavailability of Carvedilol

RECENT ADVANCES OF Β-BLOCKERS AS DRUG REPURPOSING APPROACH: A SYSTEMATIC REVIEW

SOME PHARMACOLOGICAL ASPECTS OF ULTRA-SHORT ACTING B-BLOCKER (ESMOLOL)

Aliskiren and L-carnitine attenuate isoproterenol-induced cardiac hypertrophy via targeting IL-6/JAK2/STAT3/SOCS3 signaling pathway